Susquehanna International Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Susquehanna International Group’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-17,300	Closed	-$585K	–	14121
2021 Q2	$585K	Sell	17,300 -96,700	-85%	-$2.46M	﹤0.01%	9224
2021 Q1	$2.67M	Buy	114,000 +72,000	+171%	+$2.18M	﹤0.01%	5230
2020 Q4	$1.21M	Buy	42,000 +31,700	+308%	+$798K	﹤0.01%	6265
2020 Q3	$209K	Sell	10,300 -1,300	-11%	-$31.7K	﹤0.01%	9382
2020 Q2	$349K	Buy	11,600 +4,800	+71%	+$173K	﹤0.01%	8086
2020 Q1	$214K	Buy	+6,800	New	+$236K	﹤0.01%	8569

Susquehanna International Group's CNST Position: Q3 2021 in Review

Susquehanna International Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 19,013 shares — an estimated $643K sold.

Susquehanna International Group first reported a position in CNST in Q1 2020 and held it in 6 quarters. The position peaked at $1.26M in Q2 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Susquehanna International Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Susquehanna International Group sold 19,013 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $643K.
Susquehanna International Group first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 6 quarters.
Susquehanna International Group's Constellation Pharmaceuticals, Inc. position peaked at $1.26M in Q2 2020.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.